Skip to content
Our reporters bring you news and highlights from BIO’s in-person and virtual events.
On Day 1 of the BIO CEO and Investor Conference, a panel—Prioritizing CRO Spending Through a High-Inflation, Sparse-Funding Period—brought together experts to look at […]
5 things to know about clinical trials Read More »
“It’s exciting times,” said Kathy Fernando, Senior Vice President and Global Head of the Partner of Choice Organization at Pfizer Inc. Speaking about the
Pfizer Ignite’s new model is turning heads and sharing the wealth Read More »
The teams behind Good Day BIO and Bio.News is live at the BIO CEO and Investor Conference in New York. The Marriott Marquis in
How to follow the BIO CEO and Investor Conference 2023 Read More »
Over the last 10 years, partnering has been an essential driver of the U.S. biotech business, with external partnerships increasing by 152% and tripling
Partnering is a big deal at the BIO CEO & Investor Conference in NYC, Feb. 6-7 Read More »
Start-ups looking to present their innovations in front of the biggest annual gathering of the biotech community can apply now for the Start-up Stadium
Start-up Stadium introduces biotech innovators and investors Read More »
Thanks for joining us in Year 1 of Bio.News. We published over 700 stories in less than one year – and these were the
Our Top 15 Most-Clicked Stories of 2022 Read More »
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
Nucleic acid and gene therapies are the future of medicine. However, current delivery methods pose many limitations when it comes to getting potential therapies
US President Joe Biden signed an executive order on Monday that will “help expand U.S. biomanufacturing and reduce reliance on China,” according to Bloomberg.
Biomanufacturing to get a boost from Biden’s new executive order Read More »
Two years into a global pandemic that disproportionately affected Black and Brown communities, executives are seeking to ignite change in the biotechnology ecosystem. During
Breaking the system to make a change: How biotech leaders drive diversity and inclusion Read More »
